Innovations in Immunotherapy and Cancer Vaccines: From Bench to Bedside
A special issue of Vaccines (ISSN 2076-393X).
Deadline for manuscript submissions: 16 June 2026 | Viewed by 26
Special Issue Editor
Interests: immunotherapy; immunology; cancer and cell biology; targeted therapies; biomarkers; developmental pathways
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In recent years, cancer immunotherapy has transformed the oncology landscape by leveraging the immune system's ability to detect and eliminate malignant cells. Among the most impactful strategies, immune checkpoint inhibitors, adoptive cell therapies, and cancer vaccines have shown remarkable clinical efficacy across a range of tumor types.
This Special Issue will highlight cutting-edge advancements in immunotherapy and the rapidly evolving field of cancer vaccine development. We welcome original research articles, reviews, and perspectives that address critical areas including neoantigen identification, mRNA-based cancer vaccines, the modulation of the tumor microenvironment, combination immunotherapeutic approaches, and personalized vaccination strategies.
Particular emphasis will be placed on translational studies that bridge the gap between preclinical discoveries and clinical application, with the goal of accelerating the development of effective, durable, and individualized cancer immunotherapy treatment. By gathering interdisciplinary contributions, this Special Issue will offer a comprehensive overview of current challenges, innovative solutions, and future directions in this field.
We invite submissions of original research articles, systematic reviews, short communications, and other relevant formats. All manuscripts will undergo rigorous peer review in accordance with MDPI’s standards.
We look forward to receiving your contributions to this timely and impactful collection.
Dr. Paul Takam Kamga
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer
- immunotherapy
- vaccine
- preclinical and clinical studies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
